Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
May 31, 2026 -0.30M
February 28, 2026 0.744M
November 30, 2025 -0.451M
August 31, 2025 -99.39M
May 31, 2025 -0.094M
February 28, 2025 0.945M
November 30, 2024 -1.409M
August 31, 2024 0.979M
May 31, 2024 0.013M
February 29, 2024 1.302M
November 30, 2023 0.079M
August 31, 2023 1.062M
May 31, 2023 0.252M
February 28, 2023 -39.98M
November 30, 2022 -79.26M
August 31, 2022 0.905M
May 31, 2022 -1.029M
February 28, 2022 1.223M
November 30, 2021 5.571M
August 31, 2021 1.048M
May 31, 2021 10.74M
February 28, 2021 10.14M
November 30, 2020 7.563M
August 31, 2020 5.095M
May 31, 2020 1.49M
Date Value
February 29, 2020 8.702M
November 30, 2019 10.50M
August 31, 2019 8.708M
May 31, 2019 3.282M
February 28, 2019 0.349M
November 30, 2018 1.276M
August 31, 2018 8.992M
May 31, 2018 4.345M
February 28, 2018 2.521M
November 30, 2017 14.44M
August 31, 2017 1.956M
May 31, 2017 5.555M
February 28, 2017 6.694M
November 30, 2016 8.04M
August 31, 2016 4.781M
May 31, 2016 4.274M
February 29, 2016 1.98M
November 30, 2015 2.881M
August 31, 2015 6.173M
May 31, 2015 4.552M
February 28, 2015 2.101M
November 30, 2014 0.582M
August 31, 2014 3.798M
May 31, 2014 7.38M
February 28, 2014 3.14M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
IDEXX Laboratories, Inc. -325.19M
QuidelOrtho Corp. 200.60M
Aspira Women's Health, Inc. 1.293M
VolitionRX Ltd. 4.778M
Lucid Diagnostics, Inc. 16.85M